NPI: 1689693319 · HENDERSON, NV 89052 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/19/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 07/19/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,882 | $186K |
| 2019 | 24,134 | $183K |
| 2020 | 19,262 | $128K |
| 2021 | 17,982 | $207K |
| 2022 | 20,639 | $267K |
| 2023 | 6,396 | $242K |
| 2024 | 1,293 | $171K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 37,067 | 1,473 | $1.38M |
| A4657 | Syringe, with or without needle, each | 2,725 | 1,022 | $117.10 |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 40,084 | 1,011 | $117.00 |
| J1756 | Injection, iron sucrose, 1 mg | 4,513 | 540 | $11.50 |
| J1270 | Injection, doxercalciferol, 1 mcg | 13,675 | 632 | $5.16 |
| 85048 | 1,862 | 746 | $0.00 | |
| 83970 | 1,467 | 560 | $0.00 | |
| 85041 | 1,871 | 751 | $0.00 | |
| 82108 | 303 | 136 | $0.00 | |
| 83540 | 931 | 391 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 77 | 13 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 431 | 129 | $0.00 |
| 82728 | 828 | 360 | $0.00 | |
| 83550 | 754 | 355 | $0.00 |